Cover Image
Market Research Report
Product code 
1075699

In-vitro Fertilization Market - Forecast(2022 - 2027)

Published: | IndustryARC | 107 Pages | Delivery time: 2-3 business days

Price

Back to Top
In-vitro Fertilization Market - Forecast(2022 - 2027)
Published: January 7, 2022
IndustryARC
Content info: 107 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

In-vitro Fertilization Market size is estimated to reach $20.7 billion by 2027, growing at a CAGR of 6.5% during the forecast period 2022-2027. In vitro fertilization (IVF) is a type of assistive reproductive technology (ART) that is used to help with fertility and assist with the conception of a child. It gives the opportunity of having a child using their own eggs for women with blocked fallopian tubes. In-vitro fertilization (IVF) and intrauterine insemination (IUI) are two common methods adopted for fertility treatment. Rise in the demand for advanced imaging systems and IVF cabinet, increase in the number of fertility clinics, rise in the government support for fertility treatment, growing favorable policies for infertility treatment, and increase in the median age of first-time motherhood in developed nations are the factors that are set to drive the growth of the In-vitro Fertilization Market for the period 2022-2027.

Report Coverage

The report: "In-vitro Fertilization Market Forecast (2022-2027)", by Industry ARC, covers an in-depth analysis of the following segments of the In-vitro Fertilization Market.

By Type: Fresh Nondonor, Frozen Nondonor, Fresh Donor, and Frozen Donor.

By Product Type: Imaging Systems, Sperm Separation System, IVF Cabinet, Incubators, Cryosystems, Ovum Aspiration Pumps, and Others.

By End User: Hospitals, Fertility Clinics, Clinical Research Institutes, and Others.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

Geographically, North American In-vitro Fertilization Market accounted for the highest revenue share in 2020 and is poised to dominate over the period 2022-2027 owing to the growing demand for advanced imaging systems and IVF cabinet.

The rise in the success rate of the procedure in the first attempt is driving the Fresh Nondonor segment. However, the high cost of IVF treatment is one of the major factors that is said to reduce the growth of the In-vitro Fertilization Market.

Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the In-vitro Fertilization Market report.

In-vitro Fertilization Market Segment Analysis-By Type

The In-vitro Fertilization Market based on the Type can be further segmented into Fresh Nondonor, Frozen Nondonor, Fresh Donor, and Frozen Donor. The Fresh Nondonor segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 7.1% over the period 2022-2027. This growth can be attributed to factors such as rise in the success rate of the procedure in the first attempt and increase in the demand for assisted reproductive technologies. The growing number of fresh nondonors banking the eggs or embryos is driving the growth of the In-vitro Fertilization Market. The Frozen Non-donor segment held the second largest share in 2020 owing to its cost-effectiveness and also the drug stimulation process is not required for the recipient and is less invasive. Many favorable policies in developed nations also encouraged people to donate their sperm, which is driving the growth of the In-vitro Fertilization Market.

In-vitro Fertilization Market Segment Analysis-By End User

The In-vitro Fertilization Market based on the End User can be further segmented into Hospitals, Fertility Clinics, Clinical Research Institutes, and Others. The Fertility Clinics segment held the largest share in 2020 and is also estimated to be the fastest growing segment with a CAGR of 7.3% over the period 2022-2027. This growth is owing to the factors such as growing demand for ART treatments and rise in the number of fertility clinics in developed nations. The increase in the investments by the key players is driving the growth of the In-vitro Fertilization Market. The Hospitals segment held the second largest share in 2020 owing to the factors such as low treatment costs and growing adoption of hospital-based environment for the treatment of In-vitro fertilization (IVF) and intrauterine insemination (IUI).

In-vitro Fertilization Market Segment Analysis-By Geography

North America held the largest share with 31% of the overall market in 2020. The growth in this segment is owing to the factors such as rise in the number of fertility centers and growing favorable policies for infertility treatment. The rise in the demand for advanced imaging systems and IVF cabinet is driving the growth of the In-vitro Fertilization Market. Asia-Pacific is estimated to be the fastest growing segment over the period 2022-2027. The growth in this segment is owing to the factors such as increase in the government support for fertility treatment and rise in the adoption of In-vitro fertilization (IVF) and intrauterine insemination (IUI) for fertility treatment.

In-vitro Fertilization Market Drivers

Rise in the Adoption of In-vitro Fertilization (IVF) for Fertility Treatment in Developed Nations

In-vitro fertilization (IVF) is increasingly being adopted in developed nations for fertility treatment as it gives the opportunity of having a child using their own eggs for women with blocked fallopian tubes. In-vitro fertilization can be used by gestational and surrogate carriers and is not restricted to the mother of the baby. Moreover, advancements in imaging systems and IVF cabinet is further driving the growth of the In-vitro Fertilization Market.

Rise in the Median Age of First-Time Motherhood

There is an increase in the median age of first-time motherhood owing to the factors such as improved contraceptive techniques and the increasing number of women prioritizing careers over starting a family. Moreover, the rate of first-time pregnancies in women under the age of 20 in developed nations has decreased rapidly, which is one of the major factors driving the growth of the In-vitro Fertilization Market.

In-vitro Fertilization Market Challenges

High Cost of IVF Treatment

The cost of IVF treatment varies from country to country owing to the lack of reimbursement policies. The cost of infertility treatments is not covered by the insurance companies. According to the National Infertility Association, fertility treatment is covered by only 25% of insurance plans, and many expenses are not covered for the IVF treatment. Moreover, the high cost of reproductive techniques to treat infertility is one of the major factors that is estimated to reduce the growth of the In-vitro Fertilization Market.

In-vitro Fertilization Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the In-vitro Fertilization Market. Key companies of this market are Vitrolife AB, EMD Sereno Inc, Merck Group, Cook Medical Inc, Genea Biomedx, CooperSurgical Inc, OvaScience, Inc, FUJIFILM Irvine Scientific, Boston IVF, and Progyny Inc among others.

Acquisitions/Product Launches:

In September 2019, FUJIFILM Irvine Scientific Inc has launched Vit Kit-NX, which is the latest addition to a portfolio of vitrification solutions for in vitro fertilization (IVF) that are designed to vitrify and warm embryos in a consistent and stable environment to achieve high pregnancy rates.

In April 2019, Vitrolife AB has acquired rights to technology using artificial intelligence for assessing embryos during in-vitro fertilization (IVF) using time-lapse videos. This technology predicts the likelihood of an embryo and shortens the time to pregnancy by helping IVF practitioners.

In February 2019, Merck has launched fertility technologies, such as Geri, Gavi, and Gems to be made to IVF clinics and hospitals. These technologies help in reducing external stresses on the embryos of patients undergoing fertility treatment.

Product Code: HCR 62608

Table of Contents

1. In-vitro Fertilization Market - Overview

  • 1.1 Definitions and Scope

2. In-vitro Fertilization Market - Executive Summary

  • 2.1 Market Revenue and Key Trends by Company
  • 2.2 Key trends by Product Type
  • 2.3 Key trends by End User
  • 2.4 Key trends by Geography

3. In-vitro Fertilization Market - Comparative Analysis

  • 3.1 Product Benchmarking - Key Companies
  • 3.2 Financial Analysis - Key Companies
  • 3.3 Market Value Split by Key Companies
  • 3.4 Patent Analysis - Key Companies
  • 3.5 Pricing Analysis

4. In-vitro Fertilization Market Forces

  • 4.1 Market Drivers
  • 4.2 Market Constraints/Challenges
  • 4.3 Porters five force model
    • 4.3.1 Bargaining power of suppliers
    • 4.3.2 Bargaining powers of customers
    • 4.3.3 Threat of new entrants
    • 4.3.4 Rivalry among existing players
    • 4.3.5 Threat of substitutes

5. In-vitro Fertilization Market - Strategic Analysis

  • 5.1 Value Chain Analysis
  • 5.2 Opportunities Analysis
  • 5.3 Market Life Cycle

6. In-vitro Fertilization Market - By Type(Market Size -$Million/$Billion)

  • 6.1 Fresh Nondonor
  • 6.2 Frozen Nondonor
  • 6.3 Fresh Donor
  • 6.4 Frozen Donor

7. In-vitro Fertilization Market - By Product Type(Market Size -$Million/$Billion)

  • 7.1 Imaging Systems
  • 7.2 Sperm Separation System
  • 7.3 IVF Cabinet
  • 7.4 Incubators
  • 7.5 Cryosystems
  • 7.6 Ovum Aspiration Pumps
  • 7.7 Others

8. In-vitro Fertilization Market - By End User(Market Size -$Million/$Billion)

  • 8.1 Hospitals
  • 8.2 Fertility Clinics
  • 8.3 Clinical Research Institutes
  • 8.4 Others

9. In-vitro Fertilization Market - By Geography(Market Size -$Million/$Billion)

  • 9.1 North America
    • 9.1.1 U.S.
    • 9.1.2 Mexico
    • 9.1.3 Canada
  • 9.2 Europe
    • 9.2.1 U.K.
    • 9.2.2 France
    • 9.2.3 Germany
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Russia
    • 9.2.7 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 India
    • 9.3.3 Japan
    • 9.3.4 South Korea
    • 9.3.5 Australia & New Zealand
    • 9.3.6 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Rest of South America
  • 9.5 Rest of the World
    • 9.5.1 Middle East
    • 9.5.2 Africa

10. In-vitro Fertilization Market - Entropy

11. In-vitro Fertilization Market Company Analysis

  • 11.1 Company 1
  • 11.2 Company 2
  • 11.3 Company 3
  • 11.4 Company 4
  • 11.5 Company 5
  • 11.6 Company 6
  • 11.7 Company 7
  • 11.8 Company 8
  • 11.9 Company 9
  • 11.10 Company 10

"*Financials for private companies would be provided on a best efforts basis".